Home/Filings/4/0001415889-22-002083
4//SEC Filing

Frost Ronald 4

Accession 0001415889-22-002083

CIK 0000856982other

Filed

Feb 28, 7:00 PM ET

Accepted

Mar 1, 8:10 PM ET

Size

18.4 KB

Accession

0001415889-22-002083

Insider Transaction Report

Form 4
Period: 2022-02-26
Frost Ronald
Chief Operating Officer
Transactions
  • Tax Payment

    Common Stock, No Par Value

    2022-02-28$65.03/sh1,942$126,28815,144 total
  • Award

    Non-qualified stock options (right to buy)

    2022-02-26+8,0948,094 total
    Exercise: $65.03From: 2023-02-28Exp: 2029-02-28Common Stock (8,094 underlying)
  • Award

    Common Stock, No Par Value

    2022-02-26+6,63017,086 total
Holdings
  • Common Stock, No Par Value

    (indirect: By 401(k))
    16,284
  • Non-qualified stock options (right to buy)

    Exercise: $28.20From: 2018-04-14Exp: 2024-04-14Common Stock (50,000 underlying)
    50,000
  • Non-qualified stock options (right to buy)

    Exercise: $16.05From: 2017-01-28Exp: 2023-01-28Common stock (20,000 underlying)
    20,000
  • Non-qualified stock options (right to buy)

    Exercise: $44.80From: 2019-03-02Exp: 2025-03-02Common Stock (40,000 underlying)
    40,000
  • Non-qualified stock options (right to buy)

    Exercise: $55.73From: 2020-03-01Exp: 2026-03-01Common Stock (30,000 underlying)
    30,000
  • Non-qualified stock options (right to buy)

    Exercise: $56.25From: 2022-03-19Exp: 2028-03-19Common Stock (9,681 underlying)
    9,681
  • Non-qualified stock options (right to buy)

    Exercise: $37.71From: 2021-02-26Exp: 2027-02-26Common Stock (16,722 underlying)
    16,722
Footnotes (9)
  • [F1]These shares were acquired upon a determination of the Company's Compensation and Talent Development Committee and Board of Directors that certain conditions had been met for the issuance of such shares pursuant to performance stock units that were granted on 02/26/2020.
  • [F2]Represents plan holdings as of 02/28/2022.
  • [F3]Becomes exercisable in equal annual installments of 25% commencing 02/28/2023.
  • [F4]Become exercisable in equal annual installments of 25% commencing 03/19/2022.
  • [F5]Become exercisable in equal annual installments of 20% commencing 01/28/2017.
  • [F6]Become exercisable in equal annual installments of 20% commencing 04/14/2018.
  • [F7]Become exercisable in equal annual installments of 20% commencing 03/02/2019.
  • [F8]Become exercisable in equal annual installments of 20% commencing 03/01/2020.
  • [F9]Become exercisable in equal annual installments of 25% commencing 02/26/2021.

Issuer

MERIT MEDICAL SYSTEMS INC

CIK 0000856982

Entity typeother

Related Parties

1
  • filerCIK 0001595939

Filing Metadata

Form type
4
Filed
Feb 28, 7:00 PM ET
Accepted
Mar 1, 8:10 PM ET
Size
18.4 KB